Poolbeg Pharma makes "interesting addition to existing collaboration"

Digital Asset Direct by Poolbeg Pharma PLC

London, UK | December 15, 2022 04:48 AM Eastern Standard Time

Poolbeg Pharma PLC (AIM:POLB, OTCQB:POLBF) CEO Jeremy Skillington speaks to Proactive after announcing an extension of the company's existing collaboration with AnaBio Technologies by agreeing to collaborate with AnaBio's sister company InsuCaps to looks at developing treatments for metabolic diseases. Skillington describes it as a "terrific opportunity" for Poolbeg.

Contact Details

Proactive UK Ltd

+44 20 7989 0813

uk@proactiveinvestors.com

Why News Direct

For Public Relations For Investor Relations Testimonials

About us Features News Hub

Resources

Press Blog

Why News Direct For Public Relations For Investor Relations Testimonials

What We Offer Collaborative Content Studio Advanced News Release Capability Standalone Multimedia Distribution Industry-Leading Security Unsurpassed Global Reach Actionable Analytics Synergistic PR Solutions

Pricing About us News Hub

Resources Blog Press